Related references
Note: Only part of the references are listed.Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
Eamonn M. M. Quigley
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis
Jill M. Hoffman et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Effect of TongXie-YaoFang on Cl- and HCO3- Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats
Xiaofang Lu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Treatment Targets in Inflammatory Bowel Disease: Current Status in Daily Practice
Tessa E. H. Romkens et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2016)
Regulating effect of TongXie-YaoFang on colonic epithelial secretion via Cl- and HCO3- channel
Cheng Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Identification of a novel interaction between corticotropin releasing hormone (Crh) and macroautophagy
Panagiotis Giannogonas et al.
SCIENTIFIC REPORTS (2016)
Cellular inhibitor of apoptosis protein 2 controls human colonic epithelial restitution, migration, and Rac1 activation
Jakob Benedict Seidelin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
New targets for mucosal healing and therapy in inflammatory bowel diseases
M. F. Neurath
MUCOSAL IMMUNOLOGY (2014)
The overlap between IBS and IBD - what is it and what does it mean?
Vladimir Stanisic et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor
Xuguang Hu et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Brain-Gut Interactions in Inflammatory Bowel Disease
Bruno L. Bonaz et al.
GASTROENTEROLOGY (2013)
CRF2 Signaling Is a Novel Regulator of Cellular Adhesion and Migration in Colorectal Cancer Cells
Benjamin Ducarouge et al.
PLOS ONE (2013)
Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: Down-regulation in ulcerative colitis
Ekaterini Chatzaki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Hospitalisations and surgery in Crohn's disease
Charles N. Bernstein et al.
GUT (2012)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation
Judith E. Baars et al.
INFLAMMATORY BOWEL DISEASES (2012)
Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts
Fernando Magro et al.
INFLAMMATORY BOWEL DISEASES (2012)
Inflammatory bowel disease in the 21st century in China: Turning challenges into opportunities
Qin Ouyang et al.
JOURNAL OF DIGESTIVE DISEASES (2012)
CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice
Hang Thi Thu Nguyen et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Corticotropin-Releasing Factor Regulates TLR4 Expression in the Colon and Protects Mice From Colitis
Zoi Chaniotou et al.
GASTROENTEROLOGY (2010)
Corticotropin-Releasing Hormone Family of Peptides Regulates Intestinal Angiogenesis
Eunok Im et al.
GASTROENTEROLOGY (2010)
Epithelial restitution and wound healing in inflammatory bowel disease
Andreas Sturm et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Role of the intestinal barrier in inflammatory bowel disease
Mike G. Laukoetter et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach:: Protective biological role by inhibition of apoptosis
Ekaterini Chatzaki et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: Implications for physiology and pathophysiology
EW Hillhouse et al.
ENDOCRINE REVIEWS (2006)
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
P Rutgeerts et al.
GASTROINTESTINAL ENDOSCOPY (2006)
Effects of four regulating-intestine prescriptions on pathology and ultrastructure of colon tissue in rats with ulcerative colitis
Heng Fan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Trefoil factors: Initiators of mucosal healing
D Taupin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Clinical aspects and pathophysiology of inflammatory bowel disease
BA Hendrickson et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Share Paper
